Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol–starch components

The purpose of this study was to evaluate different bioadhesive ocular formulations based on drum dried waxy maize ® starch (DDWM), Amioca ® starch and Carbopol ® 974P. The concentrations of Carbopol ® 974P in the mixtures varied between 5 and 25% (w/w). The rheological properties of the non-sterili...

Full description

Saved in:
Bibliographic Details
Published inEuropean journal of pharmaceutics and biopharmaceutics Vol. 62; no. 2; pp. 202 - 209
Main Authors Weyenberg, W., Bozdag, S., Foreman, P., Remon, J.P., Ludwig, A.
Format Journal Article
LanguageEnglish
Published Amsterdam Elsevier B.V 01.02.2006
Elsevier Science
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The purpose of this study was to evaluate different bioadhesive ocular formulations based on drum dried waxy maize ® starch (DDWM), Amioca ® starch and Carbopol ® 974P. The concentrations of Carbopol ® 974P in the mixtures varied between 5 and 25% (w/w). The rheological properties of the non-sterilized and gamma-irradiated physical blends of Carbopol ® 974P with either DDWM or Amioca ® were compared to those of the corresponding co-spray dried Amioca ® starch/Carbopol ® powders. Higher viscosity or consistency values were measured for sterilized co-spray dried powder mixtures containing an amount of Carbopol ® 974P equal or above 15% (w/w) compared to the physical blends. Sustained release minitablets (Ø 2 mm, 6 mg), consisting of sodium fluorescein as model drug and the bioadhesive powders, were manufactured at a compression force of 1.25 kN. Afterwards, the tablets were sterilized with gamma-irradiation. The amount of Carbopol ® in the co-spray dried powder mixtures on the one hand and gamma-irradiation on the other hand had no significant influence on the crushing strength and friability of the minitablets evaluated. However, these two factors affected the in vitro release properties of the minitablets. The slowest release was obtained with tablets containing 25% Carbopol ® 974P, which unfortunately possess mucosal irritating properties. By using co-spray dried Amioca ® with 15% (w/w) Carbopol ® 974P, a slower release can be achieved compared to the physical mixtures of DDWM or Amioca ® starch with Carbopol ® 974P. Moreover, this ocular formulation is very promising and is preferred, as it did not cause any mucosal irritation and released the model drug for at least 12 h, after application in the fornix.
AbstractList The purpose of this study was to evaluate different bioadhesive ocular formulations based on drum dried waxy maize ® starch (DDWM), Amioca ® starch and Carbopol ® 974P. The concentrations of Carbopol ® 974P in the mixtures varied between 5 and 25% (w/w). The rheological properties of the non-sterilized and gamma-irradiated physical blends of Carbopol ® 974P with either DDWM or Amioca ® were compared to those of the corresponding co-spray dried Amioca ® starch/Carbopol ® powders. Higher viscosity or consistency values were measured for sterilized co-spray dried powder mixtures containing an amount of Carbopol ® 974P equal or above 15% (w/w) compared to the physical blends. Sustained release minitablets (Ø 2 mm, 6 mg), consisting of sodium fluorescein as model drug and the bioadhesive powders, were manufactured at a compression force of 1.25 kN. Afterwards, the tablets were sterilized with gamma-irradiation. The amount of Carbopol ® in the co-spray dried powder mixtures on the one hand and gamma-irradiation on the other hand had no significant influence on the crushing strength and friability of the minitablets evaluated. However, these two factors affected the in vitro release properties of the minitablets. The slowest release was obtained with tablets containing 25% Carbopol ® 974P, which unfortunately possess mucosal irritating properties. By using co-spray dried Amioca ® with 15% (w/w) Carbopol ® 974P, a slower release can be achieved compared to the physical mixtures of DDWM or Amioca ® starch with Carbopol ® 974P. Moreover, this ocular formulation is very promising and is preferred, as it did not cause any mucosal irritation and released the model drug for at least 12 h, after application in the fornix.
The purpose of this study was to evaluate different bioadhesive ocular formulations based on drum dried waxy maize starch (DDWM), Amioca starch and Carbopol 974P. The concentrations of Carbopol 974P in the mixtures varied between 5 and 25% (w/w). The rheological properties of the non-sterilized and gamma-irradiated physical blends of Carbopol 974P with either DDWM or Amioca were compared to those of the corresponding co-spray dried Amioca starch/Carbopol powders. Higher viscosity or consistency values were measured for sterilized co-spray dried powder mixtures containing an amount of Carbopol 974P equal or above 15% (w/w) compared to the physical blends. Sustained release minitablets (2 mm, 6 mg), consisting of sodium fluorescein as model drug and the bioadhesive powders, were manufactured at a compression force of 1.25 kN. Afterwards, the tablets were sterilized with gamma-irradiation. The amount of Carbopol in the co-spray dried powder mixtures on the one hand and gamma-irradiation on the other hand had no significant influence on the crushing strength and friability of the minitablets evaluated. However, these two factors affected the in vitro release properties of the minitablets. The slowest release was obtained with tablets containing 25% Carbopol 974P, which unfortunately possess mucosal irritating properties. By using co-spray dried Amioca with 15% (w/w) Carbopol 974P, a slower release can be achieved compared to the physical mixtures of DDWM or Amioca starch with Carbopol 974P. Moreover, this ocular formulation is very promising and is preferred, as it did not cause any mucosal irritation and released the model drug for at least 12 h, after application in the fornix.
Author Foreman, P.
Bozdag, S.
Remon, J.P.
Ludwig, A.
Weyenberg, W.
Author_xml – sequence: 1
  givenname: W.
  surname: Weyenberg
  fullname: Weyenberg, W.
  organization: Laboratory of Pharmaceutical Technology and Biopharmacy, University of Antwerp, Antwerp, Belgium
– sequence: 2
  givenname: S.
  surname: Bozdag
  fullname: Bozdag, S.
  organization: Laboratory of Pharmaceutical Technology and Biopharmacy, University of Antwerp, Antwerp, Belgium
– sequence: 3
  givenname: P.
  surname: Foreman
  fullname: Foreman, P.
  organization: National Starch and Chemical Company, Bridgewater, USA
– sequence: 4
  givenname: J.P.
  surname: Remon
  fullname: Remon, J.P.
  organization: Laboratory of Pharmaceutical Technology, Ghent University, Ghent, Belgium
– sequence: 5
  givenname: A.
  surname: Ludwig
  fullname: Ludwig, A.
  email: annick.ludwig@ua.ac.be
  organization: Laboratory of Pharmaceutical Technology and Biopharmacy, University of Antwerp, Antwerp, Belgium
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17468984$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16209917$$D View this record in MEDLINE/PubMed
BookMark eNp9kMuKFDEUhoOMOD2jL-BCsnFZ5cmlqlLgRhpvMOBG1yGVnNBpqpMiSbfoQnwH39AnsZpumJ2rA4fvP5z_uyM3MUUk5CWDlgHr3-xb3C9TywG6FlQLIJ6QDVODaISU7IZsYBRj00vGbsldKXsAkEOnnpFb1nMYRzZsyK_tzmRjK-bw09SQIjXR0RDpKZwSxZOZj5d18jTZ42wyPYQYqplmrIUuGReT0dHvoe6oC95jxljpFJJxOyzhhHRr8pSWNP_9_adUk-2O2nRY1iqxlufkqTdzwRfXeU--fXj_dfupefjy8fP23UNjRSdqIwW3vVECfGdBjYOUHedKDsB70zmAXvC-s5IbQCetUIP3Qlkx8Mlbg-DEPeGXuzanUjJ6veRwMPmHZqDPMvVen2Xqs0wNSq8y19CrS2g5Tgd0j5GrvRV4fQVMsWb22UQbyiM3yF6NSq7c2wuHa8VTwKyLDRgtupDRVu1S-N8f_wCxLJgl
CitedBy_id crossref_primary_10_3390_coatings13111891
crossref_primary_10_1016_j_drudis_2016_02_013
crossref_primary_10_1586_17469899_2_2_309
crossref_primary_10_1016_j_ijpharm_2014_02_032
crossref_primary_10_1016_S1773_2247_11_50036_X
crossref_primary_10_1590_s2175_97902017000400216
crossref_primary_10_1111_jphp_12131
crossref_primary_10_1007_s13346_011_0018_2
crossref_primary_10_21931_RB_CSS_2023_08_03_39
crossref_primary_10_3109_03639041003718030
crossref_primary_10_1016_j_nantod_2020_101049
crossref_primary_10_1208_s12249_009_9228_z
crossref_primary_10_1517_17425247_2012_690733
Cites_doi 10.1016/S0168-3659(03)00012-9
10.1016/S0378-5173(00)00536-6
10.1016/S1350-9462(97)00002-5
10.1016/0378-5173(95)04096-X
10.1016/0378-5173(94)90219-4
10.1016/S0168-3659(01)00522-3
10.1038/eye.1995.149
10.1023/A:1016242528222
10.1016/S0168-3659(03)00130-5
10.1111/j.2042-7158.1993.tb05588.x
10.1016/S0168-3659(01)00539-9
10.1016/j.ejpb.2004.04.014
10.1016/j.ejps.2004.05.010
10.3109/03639048309044678
ContentType Journal Article
Copyright 2005 Elsevier B.V.
2006 INIST-CNRS
Copyright_xml – notice: 2005 Elsevier B.V.
– notice: 2006 INIST-CNRS
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
DOI 10.1016/j.ejpb.2005.08.003
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
DatabaseTitleList
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1873-3441
EndPage 209
ExternalDocumentID 10_1016_j_ejpb_2005_08_003
16209917
17468984
S0939641105002110
Genre Clinical Trial
Journal Article
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
29G
4.4
457
4G.
53G
5GY
5VS
7-5
71M
8P~
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AAQXK
AATCM
AAXUO
AAYOK
ABFNM
ABFRF
ABGSF
ABJNI
ABMAC
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFO
ACIUM
ACRLP
ADBBV
ADEZE
ADMUD
ADUVX
AEBSH
AEFWE
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AGHFR
AGRDE
AGUBO
AGYEJ
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ASPBG
AVWKF
AXJTR
AZFZN
BKOJK
BLXMC
C45
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
FDB
FEDTE
FGOYB
FIRID
FNPLU
FYGXN
G-Q
GBLVA
HVGLF
HZ~
IHE
J1W
KOM
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OVD
OZT
P-8
P-9
P2P
PC.
Q38
R2-
RIG
ROL
RPZ
SDF
SDG
SES
SEW
SPCBC
SSP
SSU
SSZ
T5K
TEORI
UNMZH
~G-
ABPIF
ABPTK
IQODW
AAXKI
AFJKZ
AKRWK
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
ID FETCH-LOGICAL-c353t-432c6a830f5c089744522847026a5d0063265c42a0ed4c387ff38c372bfcae0d3
IEDL.DBID .~1
ISSN 0939-6411
IngestDate Thu Sep 26 17:27:41 EDT 2024
Sat Sep 28 07:52:04 EDT 2024
Sun Oct 22 16:03:41 EDT 2023
Fri Feb 23 02:28:05 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 2
Keywords Ocular minitablet
Carbopol
In vivo study
In vitro release
Starch
Bioerodible
Evaluation
Pharmaceutical technology
Controlled release form
In vitro
Characterization
Visual system
In vivo
Formulation
Bioadhesive system
Release
Intraocular administration
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c353t-432c6a830f5c089744522847026a5d0063265c42a0ed4c387ff38c372bfcae0d3
PMID 16209917
PageCount 8
ParticipantIDs crossref_primary_10_1016_j_ejpb_2005_08_003
pubmed_primary_16209917
pascalfrancis_primary_17468984
elsevier_sciencedirect_doi_10_1016_j_ejpb_2005_08_003
PublicationCentury 2000
PublicationDate 2006-02-01
PublicationDateYYYYMMDD 2006-02-01
PublicationDate_xml – month: 02
  year: 2006
  text: 2006-02-01
  day: 01
PublicationDecade 2000
PublicationPlace Amsterdam
PublicationPlace_xml – name: Amsterdam
– name: Netherlands
PublicationTitle European journal of pharmaceutics and biopharmaceutics
PublicationTitleAlternate Eur J Pharm Biopharm
PublicationYear 2006
Publisher Elsevier B.V
Elsevier Science
Publisher_xml – name: Elsevier B.V
– name: Elsevier Science
References Adriaens, Ameye, Dhondt, Foreman, Remon (bib15) 2003; 88
Le Bourlais, Acar, Zia, Sado, Needham, Leverge (bib2) 1998; 17
Weyenberg, Todorov, Ludwig (bib9) 2004; 59
Malkowska, Khan (bib12) 1983; 9
Deschrieder (bib10) 1960; 12
Ceulemans, Vermeire, Adriaens, Remon, Ludwig (bib3) 2001; 77
Bouckaert, Remon (bib7) 1993; 45
Saettone, Chetoni, Bianchi, Giannaccini, Conte, Sangali (bib16) 1995; 126
Gurtler, Kaltsatos, Boisramé, Deleforge, Gex-Fabry, Balant, Gurny (bib1) 1995; 12
Kleinebudde (bib13) 2004; 58
Weyenberg, Vermeire, D'Haese, Vanhaelewyn, Kestelyn, Callens, Nelis, Remon, Ludwig (bib5) 2004; 23
Morgan, Tullo, Efron (bib8) 1995; 9
Sebhatu, Angberg, Ahlneck (bib11) 1994; 101
Ameye, Voorspoels, Foreman, Tsai, Richardson, Geresh, Remon (bib6) 2002; 79
Weyenberg, Vermeire, Remon, Ludwig (bib4) 2003; 89
Michailova, Titeva, Kotsilkova, Krusteva, Minkov (bib14) 2000; 209
Gurtler (10.1016/j.ejpb.2005.08.003_bib1) 1995; 12
Adriaens (10.1016/j.ejpb.2005.08.003_bib15) 2003; 88
Weyenberg (10.1016/j.ejpb.2005.08.003_bib9) 2004; 59
Sebhatu (10.1016/j.ejpb.2005.08.003_bib11) 1994; 101
Weyenberg (10.1016/j.ejpb.2005.08.003_bib4) 2003; 89
Malkowska (10.1016/j.ejpb.2005.08.003_bib12) 1983; 9
Saettone (10.1016/j.ejpb.2005.08.003_bib16) 1995; 126
Ceulemans (10.1016/j.ejpb.2005.08.003_bib3) 2001; 77
Kleinebudde (10.1016/j.ejpb.2005.08.003_bib13) 2004; 58
Michailova (10.1016/j.ejpb.2005.08.003_bib14) 2000; 209
Le Bourlais (10.1016/j.ejpb.2005.08.003_bib2) 1998; 17
Ameye (10.1016/j.ejpb.2005.08.003_bib6) 2002; 79
Weyenberg (10.1016/j.ejpb.2005.08.003_bib5) 2004; 23
Morgan (10.1016/j.ejpb.2005.08.003_bib8) 1995; 9
Deschrieder (10.1016/j.ejpb.2005.08.003_bib10) 1960; 12
Bouckaert (10.1016/j.ejpb.2005.08.003_bib7) 1993; 45
References_xml – volume: 12
  start-page: 197
  year: 1960
  end-page: 198
  ident: bib10
  article-title: Changes in starch and its degradation products on irradiating wheat flour with gamma rays
  publication-title: Starch/Stärke
  contributor:
    fullname: Deschrieder
– volume: 12
  start-page: 1791
  year: 1995
  end-page: 1795
  ident: bib1
  article-title: Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert
  publication-title: Pharm. Res.
  contributor:
    fullname: Gurny
– volume: 89
  start-page: 329
  year: 2003
  end-page: 340
  ident: bib4
  article-title: Characterization and evaluation of ocular bioadhesive minitablets compressed at different forces
  publication-title: J. Control. Release
  contributor:
    fullname: Ludwig
– volume: 88
  start-page: 393
  year: 2003
  end-page: 399
  ident: bib15
  article-title: Evaluation of the mucosal irritation potency of co-spray dried Amioca
  publication-title: J. Control. Release
  contributor:
    fullname: Remon
– volume: 58
  start-page: 317
  year: 2004
  end-page: 326
  ident: bib13
  article-title: Review article: Roll compaction/dry granulation: pharmaceutical applications
  publication-title: Eur. J. Pharm. Biopharm.
  contributor:
    fullname: Kleinebudde
– volume: 209
  start-page: 45
  year: 2000
  end-page: 56
  ident: bib14
  article-title: Water uptake and relaxation processes in mixed unlimited swelling hydrogels
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Minkov
– volume: 17
  start-page: 33
  year: 1998
  end-page: 58
  ident: bib2
  article-title: Ophthalmic Drug Delivery Systems - Recent Advances
  publication-title: Prog. Retin. Eye Res.
  contributor:
    fullname: Leverge
– volume: 77
  start-page: 333
  year: 2001
  end-page: 344
  ident: bib3
  article-title: Evaluation of a mucoadhesive tablet for ocular use
  publication-title: J. Control. Release
  contributor:
    fullname: Ludwig
– volume: 23
  start-page: 77
  year: 2004
  end-page: 87
  ident: bib5
  article-title: Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation.
  publication-title: Eur. J. Pharm. Sci.
  contributor:
    fullname: Ludwig
– volume: 45
  start-page: 504
  year: 1993
  end-page: 507
  ident: bib7
  article-title: In vitro bioadhesion of a buccal, miconazole slow-release tablet
  publication-title: J. Pharm. Pharmacol.
  contributor:
    fullname: Remon
– volume: 59
  start-page: 121
  year: 2004
  end-page: 125
  ident: bib9
  article-title: Rheological evaluation of the influence of sterilisation on ocular gels using an experimental design
  publication-title: Die Pharmazie
  contributor:
    fullname: Ludwig
– volume: 101
  start-page: 237
  year: 1994
  end-page: 247
  ident: bib11
  article-title: Assessment of the degree of disorder in crystalline solids
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Ahlneck
– volume: 126
  start-page: 79
  year: 1995
  end-page: 82
  ident: bib16
  article-title: Controlled release of timolol maleate from coated opththalmic mini-tablets prepared by compression
  publication-title: Int. J. Pharm.
  contributor:
    fullname: Sangali
– volume: 79
  start-page: 173
  year: 2002
  end-page: 182
  ident: bib6
  article-title: Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly(acrylic) acid copolymers and starch/poly(acrylic acid) mixtures
  publication-title: J. Control. Release
  contributor:
    fullname: Remon
– volume: 9
  start-page: 615
  year: 1995
  end-page: 618
  ident: bib8
  article-title: Infrared thermography of the tear film in dry eye
  publication-title: Eye
  contributor:
    fullname: Efron
– volume: 9
  start-page: 331
  year: 1983
  end-page: 347
  ident: bib12
  article-title: Effect of recompression on the properties of tablets prepared by dry granulation
  publication-title: Drug Dev. Ind. Pharm.
  contributor:
    fullname: Khan
– volume: 12
  start-page: 197
  year: 1960
  ident: 10.1016/j.ejpb.2005.08.003_bib10
  article-title: Changes in starch and its degradation products on irradiating wheat flour with gamma rays
  publication-title: Starch/Stärke
  contributor:
    fullname: Deschrieder
– volume: 88
  start-page: 393
  year: 2003
  ident: 10.1016/j.ejpb.2005.08.003_bib15
  article-title: Evaluation of the mucosal irritation potency of co-spray dried Amioca® / poly(acrylic acid) and Amioca® / Carbopol® 974P mixtures
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(03)00012-9
  contributor:
    fullname: Adriaens
– volume: 209
  start-page: 45
  year: 2000
  ident: 10.1016/j.ejpb.2005.08.003_bib14
  article-title: Water uptake and relaxation processes in mixed unlimited swelling hydrogels
  publication-title: Int. J. Pharm.
  doi: 10.1016/S0378-5173(00)00536-6
  contributor:
    fullname: Michailova
– volume: 17
  start-page: 33
  year: 1998
  ident: 10.1016/j.ejpb.2005.08.003_bib2
  article-title: Ophthalmic Drug Delivery Systems - Recent Advances
  publication-title: Prog. Retin. Eye Res.
  doi: 10.1016/S1350-9462(97)00002-5
  contributor:
    fullname: Le Bourlais
– volume: 59
  start-page: 121
  issue: 2
  year: 2004
  ident: 10.1016/j.ejpb.2005.08.003_bib9
  article-title: Rheological evaluation of the influence of sterilisation on ocular gels using an experimental design
  publication-title: Die Pharmazie
  contributor:
    fullname: Weyenberg
– volume: 126
  start-page: 79
  year: 1995
  ident: 10.1016/j.ejpb.2005.08.003_bib16
  article-title: Controlled release of timolol maleate from coated opththalmic mini-tablets prepared by compression
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(95)04096-X
  contributor:
    fullname: Saettone
– volume: 101
  start-page: 237
  year: 1994
  ident: 10.1016/j.ejpb.2005.08.003_bib11
  article-title: Assessment of the degree of disorder in crystalline solids
  publication-title: Int. J. Pharm.
  doi: 10.1016/0378-5173(94)90219-4
  contributor:
    fullname: Sebhatu
– volume: 77
  start-page: 333
  year: 2001
  ident: 10.1016/j.ejpb.2005.08.003_bib3
  article-title: Evaluation of a mucoadhesive tablet for ocular use
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(01)00522-3
  contributor:
    fullname: Ceulemans
– volume: 9
  start-page: 615
  year: 1995
  ident: 10.1016/j.ejpb.2005.08.003_bib8
  article-title: Infrared thermography of the tear film in dry eye
  publication-title: Eye
  doi: 10.1038/eye.1995.149
  contributor:
    fullname: Morgan
– volume: 12
  start-page: 1791
  year: 1995
  ident: 10.1016/j.ejpb.2005.08.003_bib1
  article-title: Ocular availability of gentamicin in small animals after topical administration of a conventional eye drop solution and a novel long acting bioadhesive ophthalmic drug insert
  publication-title: Pharm. Res.
  doi: 10.1023/A:1016242528222
  contributor:
    fullname: Gurtler
– volume: 89
  start-page: 329
  year: 2003
  ident: 10.1016/j.ejpb.2005.08.003_bib4
  article-title: Characterization and evaluation of ocular bioadhesive minitablets compressed at different forces
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(03)00130-5
  contributor:
    fullname: Weyenberg
– volume: 45
  start-page: 504
  year: 1993
  ident: 10.1016/j.ejpb.2005.08.003_bib7
  article-title: In vitro bioadhesion of a buccal, miconazole slow-release tablet
  publication-title: J. Pharm. Pharmacol.
  doi: 10.1111/j.2042-7158.1993.tb05588.x
  contributor:
    fullname: Bouckaert
– volume: 79
  start-page: 173
  year: 2002
  ident: 10.1016/j.ejpb.2005.08.003_bib6
  article-title: Ex vivo bioadhesion and in vivo testosterone bioavailability study of different bioadhesive formulations based on starch-g-poly(acrylic) acid copolymers and starch/poly(acrylic acid) mixtures
  publication-title: J. Control. Release
  doi: 10.1016/S0168-3659(01)00539-9
  contributor:
    fullname: Ameye
– volume: 58
  start-page: 317
  year: 2004
  ident: 10.1016/j.ejpb.2005.08.003_bib13
  article-title: Review article: Roll compaction/dry granulation: pharmaceutical applications
  publication-title: Eur. J. Pharm. Biopharm.
  doi: 10.1016/j.ejpb.2004.04.014
  contributor:
    fullname: Kleinebudde
– volume: 23
  start-page: 77
  issue: 1
  year: 2004
  ident: 10.1016/j.ejpb.2005.08.003_bib5
  article-title: Effect of different sterilisation methods on the properties of bioadhesive powders and ocular minitablets, and clinical evaluation.
  publication-title: Eur. J. Pharm. Sci.
  doi: 10.1016/j.ejps.2004.05.010
  contributor:
    fullname: Weyenberg
– volume: 9
  start-page: 331
  year: 1983
  ident: 10.1016/j.ejpb.2005.08.003_bib12
  article-title: Effect of recompression on the properties of tablets prepared by dry granulation
  publication-title: Drug Dev. Ind. Pharm.
  doi: 10.3109/03639048309044678
  contributor:
    fullname: Malkowska
SSID ssj0004758
Score 1.9328297
Snippet The purpose of this study was to evaluate different bioadhesive ocular formulations based on drum dried waxy maize ® starch (DDWM), Amioca ® starch and...
The purpose of this study was to evaluate different bioadhesive ocular formulations based on drum dried waxy maize starch (DDWM), Amioca starch and Carbopol...
SourceID crossref
pubmed
pascalfrancis
elsevier
SourceType Aggregation Database
Index Database
Publisher
StartPage 202
SubjectTerms Acrylic Resins
Administration, Topical
Adult
Bioerodible
Biological and medical sciences
Carbopol
Chemistry, Pharmaceutical
Delayed-Action Preparations
Desiccation
Eye - metabolism
Female
Fluorescein - chemistry
Gamma Rays
General pharmacology
Hardness
Humans
In vitro release
In vivo study
Male
Medical sciences
Ocular minitablet
Particle Size
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Polyvinyls - chemistry
Powders
Solubility
Starch
Starch - chemistry
Tablets
Tissue Adhesives - administration & dosage
Tissue Adhesives - chemistry
Viscosity
Title Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol–starch components
URI https://dx.doi.org/10.1016/j.ejpb.2005.08.003
https://www.ncbi.nlm.nih.gov/pubmed/16209917
Volume 62
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Na9wwEBUhuQRKafq5bbLMoeTSuGtbki0dw9KwTUgINIHcjCXL1DnYZtcN5BL6H_oP-0s6Y9k1KbSHXm0ZGc1I80a8mcfYexdrJyPjgoKkA4RKDG6pVAahlYXVpYoiQ4ni-UWyuhanN_Jmiy3HWhiiVQ5nvz_T-9N6eLIYVnPRVtXiC-biOhEYviQFqr7MSmD4Q5_--DDRPETaa3TS4IBGD4UznuPlblsz3KsQpZL_LTg9afMNLlnptS7-QKB9JDp5xp4OEBKO_V_usS1XP2eHl74H9f0RXE0lVZsjOITLqTv1_Qv2sPzdotlXYEJeF1DVcFfdNTA1_4amhKYnqQK1H-moxKrbQLt2PWcd6AIXRnmVDkzV5MVXR2R4WOZrQ9oLP7__QOyJGwmIuN7UxNl4ya5PPl0tV8EgwhBYLnkXCB7bJFc8LKUNFWYf1IIdQxrmbrksCOHEibQizkNXCMtVWpZcWZ7GprS5Cwv-im3XOMMbBqVWGuEZYrrICWu10S6OjbEq1gXiNDtjH8bVz1rfayMbSWi3GdmKRDNlRrqZIZ8xORooe-QxGQaDf343f2TNaapUJEorMWOvvXmnNwkVGEfp2_-c8h3b9Tc3xILZZ9vd-ps7QCzTmXnvrHO2c_z5bHXxCww-9hM
link.rule.ids 315,783,787,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwELUQPbQSQqUfdEvZzqHiUtJNYjuxj9UKtG0BIXWRuEWx46jZQxLtBiQuq_4H_iG_BE-cNAKpHLgmjhx5xp431pt5hHwxoTQ8UMbLUDqAiUjZLRVzz9c80zIXQaAwUTw9i2YX7Oclv9wg074WBmmV3dnvzvT2tO6eTLrVnNRFMfltc3EZMRu-OAYqLLN6wRAfW6f-th54HixuRTpxtIfDu8oZR_Iyi1p1FyvIqaT_i05bdbqya5Y7sYtHELQNRcevyXaHIeG7-80dsmHKN-Tg3DWhvjmE-VBTtTqEAzgf2lPfvCXr6b8eza4EE9Iyg6KE6-K6gqH7N1Q5VC1LFbD_SIM1Vs0K6qVpSeuAN7jQ66s0oIoqzf4YZMPDNF0qFF-4-3trwafdSYDM9apE0sY7cnF8NJ_OvE6FwdOU08ZjNNRRKqifc-0Lm35gD3Yb02zylvIMIU4Ycc3C1DcZ01TEeU6FpnGocp0aP6PvyWZpZ_hAIJdCWnxmQV1gmNZSSROGSmkRyswCNT0iX_vVT2rXbCPpWWiLBG2Fqpk8QeFMn44I7w2UPHCZxEaDJ78bP7DmMFXMIiEFG5FdZ97hTYQVxkH88ZlTfiYvZ_PTk-Tkx9mvPfLKXeMgJeYT2WyWV2bfAptGjVvHvQfF5Pes
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+and+in+vivo+evaluation+of+ocular+minitablets+prepared+with+different+bioadhesive+Carbopol-starch+components&rft.jtitle=European+journal+of+pharmaceutics+and+biopharmaceutics&rft.au=WEYENBERG%2C+W&rft.au=BOZDAG%2C+S&rft.au=FOREMAN%2C+P&rft.au=REMON%2C+J.+P&rft.date=2006-02-01&rft.pub=Elsevier+Science&rft.issn=0939-6411&rft.eissn=1873-3441&rft.volume=62&rft.issue=2&rft.spage=202&rft.epage=209&rft_id=info:doi/10.1016%2Fj.ejpb.2005.08.003&rft.externalDBID=n%2Fa&rft.externalDocID=17468984
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0939-6411&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0939-6411&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0939-6411&client=summon